Two Giants Vie for Billions in S.T.D. Vaccine Market

Natasha Singer writes for The New York Times: “Two pharmaceutical giants are vying for the billions of dollars up for grabs in the market for vaccines against the human papillomavirus, or HPV, a sexually transmitted infection that can cause cervical cancer and genital warts.